NCT07341906

Brief Summary

The First part of the study will be the inclusion of our patients (those for whom a tele-expertise request has been made by their general practitioner on the OMNIDOC platform between the 1st of May 2024 and the 31st of December 2025. ) After that, the team will investigate the non opposition patient to the use of their personal information. Subsequently, the clinical study will focus on comparing the diagnosis made by chat gpt expert and a dermatologist from the University Hospital of Nice to a request of dermatology tele-expertise made by general praticioner on OMNIDOC

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

December 24, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

January 14, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 24, 2025

Last Update Submit

January 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare the diagnoses offered by artificial intelligence to those proposed by the experts on requests for tele-expertise.

    Check the correspondence between the diagnosis made by the expert and the artificial intelligence on the photos, the diagnosis and supports.

    From 01 May 2025 - 31 December 2026

Secondary Outcomes (2)

  • Compare the support and response times offered by artificial intelligence to those offered by experts for dermatology tele-expertise requests.

    From 01 May 2025 - 31 December 2026

  • Compare the differences between the responses offered by chatGPT and the specific dermatologic artificial intelligence

    From 01 May 2025 - 31 December 2026

Study Arms (3)

Expert opinion

The expert had provided a diagnosis and a support based on the guideline in France

Other: The diagnosis made by Chat Gpt

chatGPT opinion

ChatGPT will provide a diagnosis and the support based on the guideline in France

Other: The diagnosis made by Chat Gpt

Specialized AI opinion

Specialised IA will provide a diagnosis and the support based on the guideline in France

Other: The diagnosis made by Chat Gpt

Interventions

The expert had provided a diagnosis and a support based on the guideline in France

Expert opinionSpecialized AI opinionchatGPT opinion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient for whom a tele-expertise request has ben made by their general practitioner on the OMNIDOC platform between the 1st of May 2024 and the 31st of December 2025.

You may qualify if:

  • Adult with a request on OMNIDOC made by their general practitioner.
  • Adult not opposed Social Security affiliation.
  • Diagnosis made by a dermatologist.

You may not qualify if:

  • Pediatric case.
  • Unusable image.
  • Absence of diagnosis made by a dermatologist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NICE

Nice, Alpes Maritimes, 06000, France

Location

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 24, 2025

First Posted

January 14, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

January 14, 2026

Record last verified: 2025-12

Locations